Future growth
Future growth - $17Q1 analysis on 6ix (Pharmaron Beijing Co., Ltd. Class A)
Track Pharmaron Beijing Co., Ltd. Class A (17Q1) on 6ix - releases, events, and the audience already following the stock.
Pharmaron Beijing Co., Ltd. Class A
Future growth for $17Q1 (Pharmaron Beijing Co., Ltd. Class A) on 6ix - drill into the data behind a Simply Wall St-style analysis.